medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre.

Similar documents
THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system

Commissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018

Commissioning Statement

Placename CCG. Policies for the Commissioning of Healthcare

Implementation of Freestyle Libre prescribing guidance across the NHS in London

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults

FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ

Description of the technology

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)

How can I access flash glucose monitoring if I need it? Support pack. This pack will help you to find out more about flash and how you can access it.

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

Blood Glucose monitoring during extra-corporeal renal therapy and plasmapheresis.

Placename CCG. Policies for the Commissioning of Healthcare

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

Information leaflet for MDI patients. Improving Diabetes using Diasend

INFORMATION ON DRIVING AND DIABETES: GROUP 2 VEHICLES

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus. Children and young people with diabetes mellitus

Country Health SA Local Health Network. Title: Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) Ambulatory Service

Preconception advice for women with type 1 and 2 diabetes. Points to consider before or as soon as you learn that you are pregnant.

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

Standard Operating Procedure Completion of DAFNE data collection: Core baseline form F04.007

24 Hour Support. Telephone Available 24 hours a day, 7 days a week

TYPE 1 DIABETES on a pump

In Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus

Commissioning Policy

Continuous Glucose Monitoring

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Agenda Item 10 - Glucose Monitoring Device for Individuals with Diabetes

Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim

Continuous Glucose Monitoring (CGM)/Real-Time Flash Glucose Scanning (FGS) Training for Healthcare Professionals and Patients

02/GMS/0030 ADULT EPILEPSY SERVICE CCP for General Medical and Surgical POOLE HOSPITAL NHS FOUNDATION TRUST

Type 2 Diabetes Recommended SMBG

Trust Protocol for the Administration of Intravenous Methylprednisolone for Thyroid Eye Disease A Protocol. The Clinical Investigation Unit (CIU)

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

A GUIDE TO STARTING HUMALOG

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

Pathway for Adult Patients with Diabetes attending the Emergency Department (ED) with Hypoglycaemia

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

FLIPS FreeStyle Libre in Pregnancy Study

Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis

REPORT INTERPRETATION

June 2016 Review: June 2019

NICE to. know... The facts you need to make the most of your diabetes care.

Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit:

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Diabetes Subcommittee of PTAC meeting held 3 March (minutes for web publishing)

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

Standard Operating Procedure 11. Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8

DIABETES: SAFE DRIVING AND THE DVLA

DIABETES STRUCTURED EDUCATION IN WORCESTERSHIRE Information for Healthcare Professionals May 2011

Trust Guideline for the Management of: Insulin Pump Therapy in Children with Type 1 Diabetes

National Diabetes Inpatient Audit (NaDIA) 2016

The management of diabetes

Parkinson s Specialist Practitioner

For Safe and Effective Diabetes Management

Connecting to Children s Diabetes

Community Sleep Studies Hub and Spoke service Community first attends (schedule 1) and Community follow-ups (schedule 2)

New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people

NHS Greater Glasgow and Clyde Adult Blood Glucose Meter and Test Strip Formulary

University College Hospital. Blood glucose and HbA 1 c targets

Optimising Insulin Pen Needles

DIABETES MANAGEMENT POLICY

State of California Health and Human Services Agency Department of Health Care Services

Endoscopy or colonoscopy guidelines

RELEASED. first steps. Icon Icon name What it means

home monitoring diary

Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations

QOF Indicator DM013:

A new model for prescribing varenicline

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

Guidelines for managing the health care needs of children and young persons with diabetes in education

Quick Reference Guide

ESCA: Cinacalcet (Mimpara )

CASE 8 Unwell insulin-dependent diabetic

ssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients

CIT-06 Eligibility Questionnaire

DATE RECEIVED 09/10/2017 SUBJECT Formulary PASSED TO Mary DATE PASSED 09/10/2017 RESPOND BY 27/10/2017 CATEGORY Business FoI NUMBER

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting

Clinical News and Innovation in Type 1 Diabetes and Technology. Parth Narendran University Hospitals Birmingham

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Policy for Supporting. Children and Young People with. Diabetes in Education

Quick Reference Guide

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Diabetes Medical Management Plan

Children & Young People Travelling with Type 1 Diabetes

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit

Transcription:

Pathway for the Managed Access of FreeStyle Libre (Flash Glucose monitoring) for Adults and Children in the care of Trust Specialist Diabetes Clinics in Northern Ireland www.hscboard.hscni.net/download/publications/pharmacy_and_ medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre.docx This pathway is for use by secondary care diabetes health care professionals, to assess if patients are suitable for a trial period of the FreeStyle Libre system or for supply of sensors on prescription (for those who have previously been self-funding). It does not cover assessment of patients for continuous glucose monitoring. The pathway provides criteria and additional points for consideration to support clinical decision making processes. The application of the points for consideration will be dependent upon clinical judgement and individual patient circumstances. Note: The use of FreeStyle Libre in pregnancy is outside the scope of this pathway Criteria for a 3-6 month trial of FreeStyle Libre (NOTE: These criteria must also be met when establishing if patients who have been selffunding are now eligible for supply of sensors on prescription). 1) Type 1 Diabetes. 2) Have undergone (or willing to undertake) previous advanced insulin selfmanagement education e.g. DAFNE, BERTIE, CHOICE. Additional clinical points to be considered: 3) Utilising effective basal bolus insulin self-management with evidence of CHO counting and correction insulin use with an SMBG frequency of >4 tests daily. 4) Problematic BG Control or difficulties maintaining good control, despite the above e.g. a. Variable SMBG control with episodic hypoglycaemia impacting on lifestyle. b. Recurrent hypoglycaemia (> 3 episodes per week or >2 severe episodes in a year). c. Loss of hypoglycaemia Awareness Symptoms ( Modified Clarke and Gold Score >4; NICE NG17. See Appendix 1). d. Persistent Elevation of HbA1c despite insulin dose adjustments. e. Severe physical, psychological or occupational barriers to effective SMBG. 1

5) Substantial evidence of benefit in maintaining good glucose control with a sensor device. 6) Regular attendance at secondary care clinic. Action Pathway (for patients assessed as suitable for a trial of FreeStyle Libre ) Initial assessments. Full examination and biochemical assessment of potential confounders of control (e.g. thyroid/adrenal/coeliac assessment). SMBG control or Diagnostic (Professional) CGM (ipro or equivalent) as a baseline assessment. All outcomes of assessments and clinical results should be recorded in the patient s medical notes. Consent and Training For first time users of FreeStyle Libre Patient consent obtained to ensure that they wish to trial the FreeStyle Libre system. Patient referred to clinic for training. Attendance at training confirmed and patient still wishes to proceed. Patient supplied with FreeStyle Libre reader and starter pack of sensors at training clinic. For ALL patients (including those who have previously self-funded FreeStyle Libre ) Patients to be informed that they will be reviewed in 3-6 months, to assess if they have met the criteria for ongoing use of FreeStyle Libre. Patient s current method of testing blood glucose and/or blood ketones to be reviewed. Note: The FreeStyle Libre reader has a built in port to enable blood glucose and ketone testing. This requires use of FreeStyle Optium blood glucose test strips and FreeStyle Optium β Ketone strips, which are NOT cost effective choices of blood glucose and ketone strips. (see price lists in appendix 6). Patients should therefore be given separate glucometer(s), which, where possible use cost effective blood glucose strips; < 10 for 50 and cost effective ketone test strips < 10 for 10, to use alongside FreeStyle Libre. Patient provided with patient information leaflet (see sample leaflets; appendix 4 and 5). This should explain the process for review, so that the patients understand, from the outset that prescribing may not continue if criteria are 2

not met and also details of what to do if they receive a faulty sensor i.e. contact Abbott Manufacturer; Customer Service Telephone number: 0800 1701177 (Mon Fri 8am -8pm) excluding bank holidays). GP Communication Letter to be issued from the training clinic to patients GP. Letter to outline the following: (see sample letters in appendix; 2 and 3). Patient has met the criteria for a 3-6 month trial of FreeStyle Libre or is now eligible to receive sensors on prescription, after previously self- funding. Patient has received training on the device. If the patient is less than 4 years old, GP to be informed that use of FreeStyle Libre is off licence. Clarification obtained from GP that they are willing to undertake prescribing. First time users have been supplied with FreeStyle Libre reader and starter pack of sensors Request GP to issue prescriptions for FreeStyle Libre sensors (maximum 2 per month). Inform GP of the patient s review date for assessment of continued use. Inform GP of the name of blood glucose test strips (and ketone strips, if appropriate), which will be used alongside the FreeStyle Libre system. Inform GP that they should contact secondary care at any time, if they are concerned as to the appropriateness of the continued use of FreeStyle Libre system for a particular patient. Review criteria Ideally 3 monthly assessments (with regular data upload) whilst on trial to confirm: 1) Use of each sensor for at least 70% of the time. 2) Effect of sensor use on reduction of BG variability and increase of percentage of time spent in target BG range (4-10mmol/L) compared to baseline 3) Improvement in the initial problem triggering the trial. If all 3 criteria are achieved, then approve continued use of sensors (reviewed annually) with expectation of ongoing regular contact and sensor upload by diabetes specialist team. 3

If use is suboptimal or does not result in effective change then sensor supply withdrawn and alternative avenues for the assistance of the individual are assessed. 4) Patient s GP to be informed by letter of outcome of the review. Advised to cease or continue prescribing of FreeStyle Libre sensors. Specialist Clinic Reporting to Diabetes Network Technology sub group 1) Quarterly report of numbers of patients assessed by GP practice 2) Quarterly report of numbers of patients offered a 3-6 month trials. 3) Quarterly report of numbers of trial successful and numbers of established users continuing effective use (after year 1). Audit Trusts will undertake to carry out regular audits to ensure that the pathway has been appropriately applied, with results reported to the Technology Subgroup. Initial audit to be undertaken after 6 months and annually thereafter. Review This pathway will be reviewed as further clinical evidence for FreeStyle Libre becomes available or guidance is issued by NICE. 4

5

Appendix 1: Clarke Hypoglycaemic Index Score 1. Pick the category that best describes you: (pick only one) I always have symptoms when my blood sugar is low 0 total I sometimes have symptoms when my blood sugar is low 1 I no longer have symptoms when my blood sugar is low 2. Have you lost some of the symptoms that used to occur when your blood sugar was low? Yes 1 total No 0 3. In the past 6 months how often have you had moderate hypoglycemia episodes? (Episodes where you might feel confused, disoriented, or lethargic and were unable to treat yourself) Never 0 total once or twice in 6 months every other month 1 once a month more than once a month 4. In the past year how often have you had severe hypoglycemia episodes? (Episodes where you were unconscious or had a seizure and needed glucagon or intravenous glucose) Never 0 total 1 time 2 times 1 3 times 4 times 5. How often in the last month have you had readings < 3.5mmol/L with symptoms? never 1 time/week 4 to 5 times/week 1 to 3 times 2 to 3 times/week almost daily 6. How often in the last month have you had readings < 3.5 mmol/l without symptoms? S c never 1 time/week 4 to 5 times/week o 1 to 3 times 2 to 3 times/week almost daily 7. How low does your blood sugar need to go before you feel symptoms? 3.4-3.9 0 total 2.8-3.3 2.2-2.7 <2.2 1 8. To what extent can you tell by your symptoms that your blood sugar is low? Always 0 total often sometimes 1 rarely never Score 1 if reading <3.5 with no symptoms Total = 6

Appendix 2: Sample letter to send to GP for first time users of FreeStyle Libre (following patient s attendance at training clinic) Dear Dr {insert name}, Your patient, {insert name} has been assessed in line with regional guidance, as eligible for a trial of the flash glucose monitoring System, FreeStyle Libre. {Insert name} has attended a training clinic on {insert date}. We have supplied the patient with a FreeStyle Libre reader and starter pack of sensors. We would be grateful if you could continue the prescribing of FreeStyle Libre sensors on a monthly basis for the patient. Each sensor lasts for 14 days, so a supply of 2 sensors per month is necessary. Patients have been advised that should they receive a faulty sensor, they should NOT request additional supplies via prescription but contact the company to obtain a replacement. (Abbott UK General Customer Service telephone number is 0800 1701177. It is open from 8am to 8pm, Monday to Friday; excluding bank holidays). {Insert name} will be reviewed on {insert date} to assess if they have met the criteria to continue long term use of the FreeStyle Libre system. We will write to you, following this review, to inform you of the outcome. In some cases ongoing prescribing of FreeStyle Libre sensors will not be required. If, at any time, you are concerned about the appropriateness of the use of FreeStyle Libre for your patient, please feel free to contact us directly. Patients will still, on occasions (e.g. to meet DVLA requirements, during periods of sickness) be required to perform blood glucose {*delete as appropriate and/or ketone blood} testing. Please prescribe {insert name of blood glucose test strip and/or ketone test strips} for use alongside the FreeStyle Libre system. Yours sincerely, {Insert prescriber s name} 7

Appendix 3: Sample letter to send to GP for patients who have already been using the FreeStyle Libre system. Dear Dr {insert name}, Your patient, {insert name} has been self- funding the FreeStyle Libre system and has been assessed in line with regional guidance, as now being eligible to obtain FreeStyle Libre sensors on prescription. The patient has their own FreeStyle Libre reader. We would be grateful if you could prescribe FreeStyle Libre sensors on a monthly basis for the patient. Each sensor lasts for 14 days, so a supply of 2 sensors per month is necessary. Patients have been advised, that should they should receive a faulty sensor, they should NOT request additional supplies via prescription but contact the company to obtain a replacement. (Abbott UK General Customer Service telephone number is 0800 1701177. It is open from 8am to 8pm, Monday to Friday; excluding bank holidays). {Insert name} will be reviewed on {insert date} to assess if they continue to meet the criteria for ongoing long term use of the FreeStyle Libre system. We will write to you, following this review, to inform you of the outcome. In some cases ongoing prescribing of FreeStyle Libre sensors will not be required. If at any time you are concerned about the appropriateness of the use of FreeStyle Libre for your patient, please feel free to contact us directly. Patients will still, on occasions (e.g. to meet DVLA requirements, during periods of sickness) be required to perform blood glucose {*delete as appropriate and/or ketone blood} testing. Please prescribe {insert name of blood glucose test strip and/or ketone test strips} for use alongside the FreeStyle Libre system. Yours sincerely, {Insert prescriber s name} 8

Appendix 4: Sample Patient Information Leaflet FreeStyle Libre (for first time users) Following assessment by your specialist diabetes team, you have been assessed as being eligible for a trial of FreeStyle Libre system. You will have received the appropriate training on the system and have been provided with a FreeStyle Libre reader and starter pack of sensors. We have written to your GP to request that they prescribe a maximum of 2 FreeStyle Libre sensors per month for you. Please note that should you receive a faulty sensor, DO NOT contact your GP for another prescription. Please contact the manufacturer (Abbott) directly for a replacement. Abbott Customer Service Telephone number: 0800 1701177 (Mon Fri 8am -8pm) excluding bank holidays). You will be reviewed at your next hospital appointment (usually in 3-6 months) where you will be assessed to check that you have met criteria to continue the prescribing of FreeStyle Libre sensors on prescription. If you meet the review criteria, prescribing of the sensors will continue and you will be reviewed on annual basis, to assess if FreeStyle Libre is still beneficial to help to manage your diabetes. In cases where the review criteria are not met, it may be necessary for your diabetes specialist to write to your GP to request that prescribing of the sensors is no longer appropriate. Your diabetes specialist will discuss with you other available options, to help manage your diabetes. You will have been made aware at your FreeStyle Libre training session that a finger-prick test using a glucometer is still required e.g. during times of rapidly changing glucose levels (i.e. acute illness), if hypoglycaemia (low blood sugars) or impending hypoglycaemia is reported, or the symptoms do not match the system readings and also prior to, and during driving, to meet current DVLA requirements. Your diabetes specialist will discuss with you the most suitable glucometer for you to use alongside your FreeStyle Libre system. If you have any queries, please feel free to contact {insert name} for further information. 9

Appendix 5: Sample Patient Information Leaflet FreeStyle Libre (for patients who have previously self-funded) Following assessment by your specialist diabetes team, you have been assessed as being eligible to receive FreeStyle Libre sensors on prescription. We have written to your GP to request that they prescribe a maximum of 2 FreeStyle Libre sensors per month for you. Please note that should you receive a faulty sensor, DO NOT contact your GP for another prescription. Please contact the manufacturer (Abbott) directly for a replacement. Abbott Customer Service Telephone number: 0800 1701177 (Mon Fri 8am -8pm) excluding bank holidays). You will be reviewed at your next hospital appointment (usually in 3-6 months) where you will be assessed to check that you have met criteria to continue the prescribing of FreeStyle Libre sensors on prescription. If you meet the review criteria, prescribing of the sensors will continue and you will be reviewed on annual basis, to assess if FreeStyle Libre is still beneficial to help to manage your diabetes. In cases where the review criteria are not met, it may be necessary for your diabetes specialist to write to your GP to request that prescribing of the sensors is no longer appropriate. Your diabetes specialist will discuss with you other available options, to help manage your diabetes. You will be aware when using the FreeStyle Libre system, that a finger-prick test using a glucometer is still required e.g. during times of rapidly changing glucose levels (i.e. acute illness), if hypoglycaemia (low blood sugars) or impending hypoglycaemia is reported, or the symptoms do not match the system readings and also prior to, and during driving, to meet current DVLA requirements. Your diabetes specialist will discuss with you the most suitable glucometer for you to use alongside your FreeStyle Libre system. If you have any queries, please feel free to contact {insert name} for further information. 10